Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Finding My Way: results of a multicentre RCT evaluating a web-based self-guided psychosocial intervention for newly diagnosed cancer survivors|
|Citation:||Supportive Care in Cancer, 2019; 27(7):2533-2544|
|Lisa Beatty, Emma Kemp, Joseph R. Coll, Jane Turner, Phyllis Butow, Donna Milne, Patsy Yates, Sylvie Lambert, Addie Wootten, Desmond Yip, Bogda Koczwara|
|Abstract:||PURPOSE:This multicentre randomised controlled trial examined the efficacy of Finding My Way (FMW), a 6-week/6-module online self-guided psychotherapeutic intervention for newly diagnosed curatively treated cancer survivors, in reducing cancer-related distress and improving quality of life compared to an online attention control. METHODS:Participants were randomised on a 1:1 ratio using a gender-stratified block design to intervention (n = 94) or attention control (n = 97), and were blinded to condition. Assessments were completed at baseline (T0), post-intervention (T1), 3 months (T2), and 6 months (T3) post-intervention. Mixed model repeated measures analyses examined differences between groups for cancer-specific distress (primary outcome) and general distress, quality of life (QoL), coping, and health service utilisation (secondary outcomes). RESULTS:While both groups reported reduced cancer-specific and general distress over time, between-group differences were not significant. Intervention participants reported lower total health service utilisation and supportive care utilisation post-intervention than controls (total HS use: between-group mean difference = - 1.07 (- 1.85 to - 0.28); supportive care use: between-group mean difference = - 0.64 (- 1.21 to - 0.06)) and significantly higher emotional functioning at 3 months (between-group mean difference = 7.04 (0.15 to 13.9)). At 6 months, the supportive care utilisation finding reversed (between-group mean difference = 0.78 points (0.19 to 1.37). Across remaining QoL and coping outcomes, no significant group differences emerged. CONCLUSIONS:While both groups experienced reductions in distress, between-group differences were not significant. This contrasts with the significantly improved emotional functioning observed in FMW participants at 3 months and the short-term reductions in health service utilisation. Long-term increases in supportive care service utilisation suggest FMW only met needs while being actively used. TRIAL REGISTRATION:ACTRN12613000001796; http://www.ANZCTR.org.au/ACTRN12613000001796.aspx.|
|Keywords:||Humans; Neoplasms; Quality of Life; Middle Aged; Female; Male; Cancer Survivors|
|Rights:||© Springer-Verlag GmbH Germany, part of Springer Nature 2018|
|Appears in Collections:||Psychology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.